U.S. House lawmakers want to know more details about how the FDA intends to handle drug and medical device shortage because of the coronavirus.
- Lawmakers also called for a briefing from FDA head
Stephen Hahn - Letter dated Monday signed by Chairman of Energy and Commerce Committee
Frank Pallone (D-NJ), Health subcommittee chairwomanAnna Eshoo (D-Calif.) and E&C Ranking MemberGreg Walden (R-Ore.)
To contact the reporter on this story:
To contact the editors responsible for this story:
Vivek Shankar
© 2020 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.